RESTRICTED STOCK (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Stock Options And Restricted Stock
Non-cash compensation expense	$ 57,455	$ 335,918
Outstanding restricted stock grants		27,842
Weighted average grant date value		$ 13.06
Nonvested at end of period	27,842	27,842
Total unrecognized compensation expense		$ 334,234
FDA Approval [Member]
Stock Options And Restricted Stock
Restricted stock to vest upon FDA approval	14,185
Four Years [Member]
Stock Options And Restricted Stock
Restricted stock to vest upon FDA approval	13,657